Company / Shares Outstanding
Tvardi Therapeutics, Inc. Shares Outstanding History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
4.5M
FY2024
5-year range
4.5M / 53.8M
FY2020-FY2024
Trend
-91.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 53480812.00 to 4540059.00 over the past 2 years.
Based on SEC 10-K filings.
4540059.00 in FY2024 with a 5-year CAGR of -35.1%.
Improved from 53480812.00 to 4540059.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -55.0%
- 5-Year CAGR
- -35.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, shares outstanding decreased 91.6% year-over-year.
- Peak shares outstanding was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 4.5M | -91.6% |
| FY2023 | 53.8M | +0.6% |
| FY2022 | 53.5M | +7.2% |
| FY2021 | 49.9M | +6.7% |
| FY2020 | 46.7M | +18.1% |
| FY2019 | 39.5M | +21.1% |
| FY2018 | 32.7M | +19.7% |
| FY2017 | 27.3M | +0.2% |
| FY2016 | 27.3M | +19.5% |
| FY2015 | 22.8M | +431.7% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026